These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20407014)

  • 1. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
    Amir S; Golan M; Mabjeesh NJ
    Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
    Amir S; Wang R; Simons JW; Mabjeesh NJ
    J Biol Chem; 2009 Apr; 284(17):11142-51. PubMed ID: 19251694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
    Golan M; Mabjeesh NJ
    Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
    Vardi-Oknin D; Golan M; Mabjeesh NJ
    PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
    Golan M; Mabjeesh NJ
    Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
    Tazat K; Schindler S; Depping R; Mabjeesh NJ
    Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of nuclear translocation of hypoxia-inducible factor-1α in influenza A (H1N1) virus infected-alveolar epithelial cells].
    Meng X; Guo X; Zhu Y; Xie H; Wang R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):8-13. PubMed ID: 32148224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
    Amir S; Wang R; Matzkin H; Simons JW; Mabjeesh NJ
    Cancer Res; 2006 Jan; 66(2):856-66. PubMed ID: 16424018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.
    Amir S; Mabjeesh NJ
    Cancer Biol Ther; 2007 Dec; 6(12):1926-31. PubMed ID: 18075300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
    Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
    J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
    Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
    Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
    Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
    Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
    Alqawi O; Moghaddas M; Singh G
    Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
    Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
    Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.